SIS
RCUS icon

Sound Income Strategies’s Arcus Biosciences RCUS Stock Holding History

Sound Income Strategies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$8.74K – 1951
2026
Q1 		$8.74K Hold
400
– – ﹤0.01% 1570
2025
Q4 		$8.72K Buy
+400
New +$8.16K ﹤0.01% 1554

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sound Income Strategies's RCUS Position: Q2 2026 in Review

Sound Income Strategies sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 400 shares — an estimated $8.74K sold.

Sound Income Strategies first reported a position in RCUS in Q4 2025 and held it in 2 quarters. The position peaked at $8.74K in Q1 2026. 154 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Sound Income Strategies reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 400 Arcus Biosciences shares in Q2 2026, an estimated $8.74K.
  • Sound Income Strategies first reported a position in Arcus Biosciences in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's Arcus Biosciences position peaked at $8.74K in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.